ImmunityBio (IBRX) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for IBRX stock
ImmunityBio, Inc. Analysis
IBRX Stock News


Popular stocks
Vale S.A.
NVIDIA
MicroAlgo
AppLovin
GameStop
Boeing
Alibaba
TAL Education
Shopify
Dell Technologies

TOP Stocks
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
Microvast
Foot Locker
T Stamp
Inspira Technologies Oxy B.H.N.
Volta
Ambarella
Mattel
RH
Mullen Automotive
Ebang International Holdings


Financial News

Popular Stocks Analysis

Investor's Journal
How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…
Are you making these mistakes when analyzing candlestick patterns?

May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?

Trading is a very popular endeavor these days, and for good reason, as it is widely accessible and allows individuals to generate additional…
Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
  1. Home
  2. Stock forecasts
  3. IBRX

ImmunityBio (IBRX) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: May 24, 2025 (14:47)

Sector: Healthcare

The share price of ImmunityBio, Inc. (IBRX) now

Latest session on the 23rd of May for
ImmunityBio, Inc. is negative
Trading Volume: 6287866
Open: 2.59 /  High: 2.63 /  Low: 2.47
Current value: $2.53
What analysts predict: $11.4
52-week High/Low: $7.63 / $1.83
50-Day Moving Average: $2.662 — resistance level today
200-Day Moving Average: $3.486 — resistance level today

Are you interested in ImmunityBio, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ImmunityBio stock price in 2025, 2026, 2027. How much will one ImmunityBio share be worth in 2025 - 2027?

When should I take profit in ImmunityBio stock? When should I record a loss on ImmunityBio stock? What are analysts' forecasts for ImmunityBio stock? What is the future of ImmunityBio stock? We forecast ImmunityBio stock performance using neural networks based on historical data on ImmunityBio stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

ImmunityBio stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ImmunityBio shares. This happens once a day.


Historical and forecast chart of ImmunityBio stock

The chart below shows the historical price of ImmunityBio stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunityBio stock price can be found in the table below.

Long-term forecasts by years.

ImmunityBio, Inc., an immunotherapy company, is developing a memory T-cell cancer vaccine to fight several types of tumors without the use of high-dose chemotherapy. He is developing albumin-linked chemotherapy (aldoxorubicin), a new cytokine superagonist IL-15 (N-803), checkpoint inhibitors, macrophage polarizing peptides, bispecific fusion proteins targeting TGFb and IL-12, adenovirus treatment and yeast vaccine. targeting tumor-associated antigens and neoepitopes. ImmunityBio Inc.

Trending Themes in the Healthcare Sector

ImmunityBio daily forecast for a month

Date Target Pes. Opt. Vol., %
May 26 2.49 2.40 2.54 5.81
May 27 2.44 2.36 2.52 6.55
May 28 2.41 2.36 2.45 4.04
May 29 2.41 2.33 2.47 5.99
May 30 2.53 2.43 2.56 5.04
May 31 2.63 2.53 2.71 7.17
Jun 01 2.60 2.51 2.66 5.90
Jun 02 2.57 2.53 2.63 3.85
Jun 03 2.59 2.57 2.64 2.88
Jun 04 2.55 2.46 2.58 5.19
Jun 05 2.57 2.49 2.64 5.94
Jun 06 2.65 2.55 2.69 5.62
Jun 07 2.61 2.57 2.66 3.67
Jun 08 2.58 2.54 2.62 3.45
Jun 09 2.60 2.54 2.67 4.96
Jun 10 2.66 2.60 2.72 4.64
Jun 11 2.70 2.64 2.79 5.63
Jun 12 2.82 2.76 2.86 3.63
Jun 13 2.80 2.76 2.89 4.93
Jun 14 2.77 2.69 2.84 5.56
Jun 15 2.77 2.73 2.87 5.27
Jun 16 2.78 2.70 2.83 4.95
Jun 17 2.80 2.75 2.90 5.24
Jun 18 2.79 2.68 2.86 6.82
Jun 19 2.79 2.70 2.89 7.13
Jun 20 2.88 2.83 2.91 2.84
Jun 21 2.81 2.77 2.87 3.61
Jun 22 2.73 2.68 2.81 4.79
Jun 23 2.67 2.62 2.77 5.55
Jun 24 2.56 2.52 2.63 4.17

ImmunityBio Daily Price Targets


ImmunityBio Stock Forecast 05-26-2025.

Forecast target price for 05-26-2025: $2.49.
Negative dynamics for ImmunityBio shares will prevail with possible volatility of 5.490%.
Pessimistic target level: 2.40
Optimistic target level: 2.54

ImmunityBio Stock Forecast 05-27-2025.

Forecast target price for 05-27-2025: $2.44.
Negative dynamics for ImmunityBio shares will prevail with possible volatility of 6.147%.
Pessimistic target level: 2.36
Optimistic target level: 2.52

ImmunityBio Stock Forecast 05-28-2025.

Forecast target price for 05-28-2025: $2.41.
Negative dynamics for ImmunityBio shares will prevail with possible volatility of 3.886%.
Pessimistic target level: 2.36
Optimistic target level: 2.45

ImmunityBio Stock Forecast 05-29-2025.

Forecast target price for 05-29-2025: $2.41.
Positive dynamics for ImmunityBio shares will prevail with possible volatility of 5.656%.
Pessimistic target level: 2.33
Optimistic target level: 2.47

ImmunityBio Stock Forecast 05-30-2025.

Forecast target price for 05-30-2025: $2.53.
Positive dynamics for ImmunityBio shares will prevail with possible volatility of 4.802%.
Pessimistic target level: 2.43
Optimistic target level: 2.56

ImmunityBio Stock Forecast 05-31-2025.

Forecast target price for 05-31-2025: $2.63.
Positive dynamics for ImmunityBio shares will prevail with possible volatility of 6.686%.
Pessimistic target level: 2.53
Optimistic target level: 2.71

IBRX (IBRX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jun. 3.33 2.97 3.73 20.44
Jul. 3.85 3.45 4.47 22.78
Aug. 3.47 3.16 3.98 20.69
Sep. 3.03 2.89 3.20 9.74
Oct. 2.43 2.31 2.75 15.95
Nov. 2.37 2.13 2.67 20.18
Dec. 2.86 2.65 3.15 16.02
Full forecast for 2025

ImmunityBio forecast for this year


ImmunityBio Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $3.33239. Pessimistic: $2.97. Optimistic: $3.73


ImmunityBio Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $3.85024. Pessimistic: $3.45. Optimistic: $4.47


ImmunityBio Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $3.47022. Pessimistic: $3.16. Optimistic: $3.98


ImmunityBio Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $3.03298. Pessimistic: $2.89. Optimistic: $3.20


ImmunityBio Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $2.4279. Pessimistic: $2.31. Optimistic: $2.75


ImmunityBio Stock Prediction for Nov 2025

An downtrend is forecast for this month with an optimal target price of $2.37181. Pessimistic: $2.13. Optimistic: $2.67


ImmunityBio Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $2.86491. Pessimistic: $2.65. Optimistic: $3.15



ImmunityBio (IBRX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.61 2.27 2.91 21.98
Feb 2.84 2.70 3.02 10.67
Mar 2.42 2.05 2.82 27.43
Apr 2.27 2.01 2.43 17.25
May 1.90 1.76 2.00 11.62
Jun 2.16 1.90 2.27 16.19
Jul 2.53 2.35 2.89 18.59
Aug 2.30 1.98 2.65 25.04
Sep 2.79 2.62 2.92 10.04
Oct 3.10 2.63 3.55 26.05
Nov 2.94 2.61 3.07 15.08
Dec 2.63 2.42 2.87 15.79
Full forecast for 2026

ImmunityBio (IBRX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 2.81 2.46 3.11 20.72
Feb 2.45 2.13 2.59 17.52
Mar 2.34 2.20 2.45 10.24
Apr 1.95 1.72 2.23 22.83
May 1.90 1.79 1.99 10.04
Jun 2.29 2.09 2.48 15.56
Jul 2.34 2.09 2.49 15.97
Aug 2.20 1.92 2.39 19.53
Sep 2.25 1.95 2.48 21.56
Oct 2.24 1.89 2.55 26.09
Nov 2.33 1.96 2.64 25.78
Dec 2.35 2.17 2.66 18.36
Full forecast for 2027

ImmunityBio information and performance

ImmunityBio Address

3530 JOHN HOPKINS COURT, SAN DIEGO, CA, US

Market Capitalization: 2 559 598 000 $

Market capitalization of the ImmunityBio, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IBRX shares in the company outstanding by the market price of one share.

EBITDA: -296 588 000 $

EBITDA of ImmunityBio is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.57

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 411.93
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 96.86

Enterprise Value (EV) /Revenue

EV To EBITDA: -8.99

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 882620000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about ImmunityBio Stock)

Should I Buy ImmunityBio Shares in 2025 year?

The maximum forecasted share price for next year is $3.10, which is $0.57 higher than the current stock price. By investing in ImmunityBio shares today for a one-year period, you could achieve a profit of 22.64%. With an investment horizon of up to two years, the target share price is $2.81. resulting in a profit of 11.21% ($0.28 per share).

Does ImmunityBio pay dividends?

No, it does not

Which economic sector do ImmunityBio's shares belong to?

ImmunityBio's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as ImmunityBio's shares?

You can view all the stocks that are part of the same sector as ImmunityBio's shares in the Healthcare section.


Related stocks from Healthcare sector

Biogen Inc. (BIIB)
Creative Medical Technology Holdings, Inc. (CELZ)
Gritstone bio, Inc. (GRTS)
Aptorum Group Limited (APM)
Trevi Therapeutics, Inc. (TRVI)
Bausch + Lomb Corporation (BLCO)
Blue Water Vaccines, Inc. (BWV)
Mesoblast Limited (MESO)
Conduit Pharmaceuticals Inc. (CDT)
MultiPlan Corp. (MPLN)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.